Search

Your search keyword '"Serratia marcescens drug effects"' showing total 1,180 results

Search Constraints

Start Over You searched for: Descriptor "Serratia marcescens drug effects" Remove constraint Descriptor: "Serratia marcescens drug effects"
1,180 results on '"Serratia marcescens drug effects"'

Search Results

1. Hospital water environment and antibiotic use: key factors in a nosocomial outbreak of carbapenemase-producing Serratia marcescens.

2. Within-host transition to GES-55 during a GES-6-producing Serratia marcescens outbreak: Emergence of ceftazidime-avibactam resistance and increased susceptibility to carbapenems.

3. Enhancing spinach (Spinacia oleracea L.) resilience in pesticide-contaminated soil: Role of pesticide-tolerant Ciceribacter azotifigens and Serratia marcescens in root architecture, leaf gas exchange attributes and antioxidant response restoration.

4. Implications of ad-hoc molecular typing for infection control measures in a multi-cluster, multi-phenotypic Serratia marcescens outbreak in a neonatal intensive care unit.

5. Prolonged hospitalization signature and early antibiotic effects on the nasopharyngeal resistome in preterm infants.

6. Umbelliferone modulates the quorum sensing and biofilm of Gram - ve bacteria: in vitro and in silico investigations.

7. Disinfection of sink drains to reduce a source of three opportunistic pathogens, during Serratia marcescens clusters in a neonatal intensive care unit.

8. Nosocomial outbreak caused by disinfectant-resistant Serratia marcescens in an adult intensive care unit, Hungary, February to March 2022.

9. Whole-genome sequencing analysis of multidrug-resistant Serratia marcescens isolates in an intensive care unit in Brazil.

10. Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.

11. Spread and evolution of bla KPC -plasmid between Serratia marcescens and Klebsiella pneumoniae.

12. Evaluation of photocatalysis inactivation in indoor air purification of pathogenic microbes by using the different nanomaterials based on TiO 2 nanomaterials.

13. Characterization of a new bacteriocin-like inhibitory peptide produced by Lactobacillus sakei B-RKM 0559.

14. A Genome-Scale Antibiotic Screen in Serratia marcescens Identifies YdgH as a Conserved Modifier of Cephalosporin and Detergent Susceptibility.

15. Three challenging cases of infections by multidrug-resistant Serratia marcescens in patients admitted to intensive care units.

16. Using ceftazidime-avibactam for persistent carbapenem-resistant Serratia marcescens infection highlights antimicrobial stewardship challenges with new beta-lactam-inhibitor combination antibiotics.

17. Antimicrobial and Antibiofilm Activities and Mechanism of Action of Chelerythrine Against Carbapenem-Resistant Serratia marcescens In Vitro .

18. Serratia marcescens SCH909 as reservoir and source of genetic elements related to wide dissemination of antimicrobial resistance mechanisms.

19. A link between pH homeostasis and colistin resistance in bacteria.

20. Repurposing of antidiabetics as Serratia marcescens virulence inhibitors.

21. The ABC-Type Efflux Pump MacAB Is Involved in Protection of Serratia marcescens against Aminoglycoside Antibiotics, Polymyxins, and Oxidative Stress.

22. Sotolon is a natural virulence mitigating agent in Serratia marcescens.

23. Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care.

24. Microwave-Assisted Rapid Green Synthesis of Gold Nanoparticles Using Seed Extract of Trachyspermum ammi : ROS Mediated Biofilm Inhibition and Anticancer Activity.

25. Identifying the Molecular Targets of an Anti-pathogenic Hydroalcoholic Extract of Punica granatum Peel Against Multidrug-resistant Serratia marcescens .

26. A promising drug delivery candidate (CS-g-PMDA-CYS-fused gold nanoparticles) for inhibition of multidrug-resistant uropathogenic Serratia marcescens .

27. Improved Biosurfactant Production by Enterobacter cloacae B14, Stability Studies, and its Antimicrobial Activity.

28. Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens.

29. Bactericidal and Antiproliferative Effects of Peripheral Parenteral Nutrition Solutions with Sodium Bisulfite on Pathogenic Microorganisms in Catheter Lumens.

30. Green synthesis of silver nanoparticles using Carum copticum: Assessment of its quorum sensing and biofilm inhibitory potential against gram negative bacterial pathogens.

31. Long-lasting nosocomial persistence of chlorhexidine-resistant Serratia marcescens in a veterinary hospital.

32. Repurposing anti-diabetic drug "Sitagliptin" as a novel virulence attenuating agent in Serratia marcescens.

33. Susceptibility evolution to antibiotics of Enterobacter cloacae, Morganella morganii, Klebsiella aerogenes and Citrobacter freundii involved in urinary tract infections: an 11-year epidemiological surveillance study.

34. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.

35. Rhizosphere assisted biodegradation of benzo(a)pyrene by cadmium resistant plant-probiotic Serratia marcescens S2I7, and its genomic traits.

36. Novel thiazolinyl-picolinamide based palladium(II) complex-impregnated urinary catheters quench the virulence and disintegrate the biofilms of uropathogens.

37. Inhibition of quorum sensing in opportunistic pathogen, Serratia marcescens, using cyclodextrin-immobilized, multiple parallel gel filaments fabricated with dynamic flow of polymer blend solution.

38. Anti-Acanthamoeba effect of potassium isostearate for use as a multipurpose solution.

39. The Development of an Antimicrobial Contact Lens - From the Laboratory to the Clinic.

40. Characterization of the active fragments of Spodoptera litura Lebocin-1.

41. Surveillance of antimicrobial resistance in Serratia marcescens in Mexico.

42. The Anti-infective Potential of Hydroalcoholic Extract of Phyllanthus emblica Seeds Against Selected Human-pathogenic Bacteria.

43. Synthesis and enzyme-based evaluation of analogues L -tyrosine thiol carboxylic acid inhibitor of metallo-β-lactamase IMP-1.

44. Gut bacteria of Cuora amboinensis (turtle) produce broad-spectrum antibacterial molecules.

45. Selective blockage of Serratia marcescens ShlA by nickel inhibits the pore-forming toxin-mediated phenotypes in eukaryotic cells.

46. Biofibers and biocomposites from sabai grass: A unique renewable resource.

47. Serratia marcescens colonization in preterm neonates during their neonatal intensive care unit stay.

48. Anti-pathogenic potential of a classical ayurvedic formulation- Triphala .

49. Anti-pathogenic potential of a classical ayurvedic   Triphala formulation.

50. Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.

Catalog

Books, media, physical & digital resources